Scientists say Ebola can be no longer an incurable disease – after a trial of two drugs from the Democratic Republic of Congo put survival rates at 0 percent.
Four experimental drugs were used in an unprecedented clinical trial from the DRC, where Ebola has killed nearly 1,900 people over the past year.
Two of the drugs – Regeneron’s REGN-EB3 in addition to a monoclonal antibody called mAb114 – were developed using antibodies harvested by Ebola survivors.
Here’s some not bad news: Doctors in addition to scientists have finally found a way to cure Ebola. Here’s how of which works
The 0 percent survival rate was for people who received the drugs shortly after being infected, when levels of the virus in their blood were low.
Researchers are to make the treatments available to anyone from the DRC infected with the virus.
The trial’s co-sponsor, the US National Institute of Allergy in addition to Infectious Diseases, said the results were “very not bad news”.